Stanley Chesler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stanley chesler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stanley Chesler Today - Breaking & Trending Today

New Jersey woman admits role in $25M securities fraud scheme

An Essex County woman admitted her role in a securities scheme that fraudulently induced victims to invest $25+ million in cash and crypto. ....

Essex County , New Jersey , United States , Stanley Chesler , Edith Pardo , Boaz Manor , Cg Blockchain Inc , Judge Stanley Chesler , Blockchain Terminal ,

NJ Judge Scraps Claims In 2 Horizon Drug Patents

A federal judge in New Jersey has ruled that claims in two Horizon Pharma patents that cover the arthritis drug Vimovo never should have been issued in the first place, sinking an infringement suit against Dr. Reddy's Laboratories that had been rattling around for half a decade. ....

Andhra Pradesh , New Jersey , United States , Stanley Chesler , Horizon Pharma Inc , Andrew Karpan , Horizon Pharma , Judge Stanley Chesler , Chicago Based Horizon Pharma ,

Federal Circuit Reaffirms That There Is No 'Reasonable Expectation Of Success' In Trying To Invalidate A Chemical Compound Claim As Obvious | Kilpatrick Townsend & Stockton LLP


To embed, copy and paste the code into your website or blog:
The Federal Circuit (in an unpublished opinion) recently reaffirmed the difficulty generic challengers face when trying to establish chemical structural obviousness to invalidate a drug compound patent claim.
1
This recent ruling involved Takeda’s U.S. Patent No. 7,807,689 (“the ‘689 Patent”), which claims alogliptin, a uracil-containing dipeptidyl peptidase IV (“DPP-IV”) inhibitor used to treat Type II diabetes. The ‘689 Patent is listed in the Orange Book for Takeda’s anti-diabetes drug products, Nesina
®, Kazano
®, and Oseni
®, each of which contains alogliptin benzoate as an active ingredient. Two ANDA applicants, Torrent and Indoco, challenged the validity of claims 4 and 12 of the ‘689 Patent as obvious under 35 U.S.C. § 103 and for non-statutory obviousness-type double patenting (“OTDP”). ....

Novartis Pharms , Otsuka Pharm , Stanley Chesler , Amerigen Pharms , Takeda Pharm , Pharma Gm , Co Ltd , Sandoz Inc , Teva Parenteral Meds Inc , Kilpatrick Townsend Stockton , Intl Ltd , Eli Lilly Co , Kilpatrick Townsend , Federal Circuit , Orange Book , Judge Stanley Chesler , Judge Chesler , Eli Lilly , Parenteral Meds , நோவர்த்திச் ஃபார்ம்ஸ் , ஓத்சுக் பார்ம் , ஸ்டான்லி செஸ்லர் , அமெரிகேன் ஃபார்ம்ஸ் , டாகேடா பார்ம் , பார்மா கம் , இணை லிமிடெட் ,